External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ASN 2024
Roche and Genentech at

ASN 2024

October 23 - October 27
San Diego, CA
asn.com
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
05:00 PM
Duration 2hrs San Diego, CA
Comparability of Two Anti-PLA2R ELISAs in Patients With Primary Membranous Nephropathy
Barbour SJ, Clarke H, Berisha E, Arjomandi A, Chen D, Riboulet W, Boston H, Prot S, Cattran DC, Place DE
Nephrology | Membranous glomerulonephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:30 PM
Duration 10mins Room 1 (Convention Center)
MAJESTY: A Phase III, Randomized, Open-Label, Active Comparator-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Obinutuzumab in Patients With Primary Membranous Nephropathy
Fervenza F, Gesualdo L, Kirsztajn GM, Hou FF, Appel G, Prot S, Berisha E, Khatri L, Parsons T, Spinks E, Boston H, Riboulet W, Han X, Chen DC, Bomback A
Nephrology | Membranous glomerulonephritis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.